Jeffrey Bacha - Net Worth and Insider Trading
Jeffrey Bacha Net Worth
The estimated net worth of Jeffrey Bacha is at least $30 dollars as of 2024-11-13. Jeffrey Bacha is the CEO of Kintara Therapeutics Inc and owns about 4 shares of Kintara Therapeutics Inc (KTRA) stock worth over $30. Details can be seen in Jeffrey Bacha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Bacha has not made any transactions after 2017-10-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey Bacha
Jeffrey Bacha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Bacha owns 2 companies in total, including Kintara Therapeutics Inc (KTRA) , and CalEthos Inc (GEDC) .
Click here to see the complete history of Jeffrey Bacha’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Bacha
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KTRA | Kintara Therapeutics Inc | 2017-12-22 | director |
GEDC | CalEthos Inc | 2008-04-03 | director |
Jeffrey Bacha Latest Holdings Summary
Jeffrey Bacha currently owns a total of 1 stock. Jeffrey Bacha owns 4 shares of Kintara Therapeutics Inc (KTRA) as of October 6, 2017, with a value of $30.
Latest Holdings of Jeffrey Bacha
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KTRA | Kintara Therapeutics Inc | 2017-10-06 | 4 | 7.54 | 30 |
Holding Weightings of Jeffrey Bacha
Jeffrey Bacha Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Bacha has made a total of 0 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 1 shares on October 6, 2017, which cost Jeffrey Bacha around $8,700.
Insider Trading History of Jeffrey Bacha
- 1
Jeffrey Bacha Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey Bacha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Bacha is -13.57%. GuruFocus also compares Jeffrey Bacha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Bacha within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey Bacha's insider trading performs compared to the benchmark.
Performance of Jeffrey Bacha
Jeffrey Bacha Ownership Network
Ownership Network List of Jeffrey Bacha
Ownership Network Relation of Jeffrey Bacha
Jeffrey Bacha Owned Company Details
What does Kintara Therapeutics Inc do?
Who are the key executives at Kintara Therapeutics Inc?
Jeffrey Bacha is the director of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and director & Head of Strategic Partnerships Saiid Zarrabian .
Kintara Therapeutics Inc (KTRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kintara Therapeutics Inc Insider Transactions
Jeffrey Bacha Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Bacha. You might contact Jeffrey Bacha via mailing address: Suite 3 1545 West 14th Avenue, Vancouver A1 V6j 2j1.